Clinuvel Pharmaceuticals (ASX:CUV) Celebrates 8th Consecutive Year of Profit Growth in FY24
Headquartered in Melbourne, Clinuvel Pharmaceuticals Limited (ASX:CUV) is an international specialty pharmaceutical company. The company is focused on developing and commercialising therapies for patients with genetic, metabolic, systemic, and life-threatening acute conditions. CUV’s flagship product is SCENESSE® (afamelanotide 16mg). Notably, the company has demonstrated …
Team Kalkine |
08 Jan 2025| Read Time : 10 Mins